Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 28, 2023

SELL
$122.5 - $147.16 $72,275 - $86,824
-590 Reduced 1.67%
34,665 $4.3 Million
Q1 2023

May 03, 2023

SELL
$133.98 - $160.47 $1.69 Million - $2.02 Million
-12,616 Reduced 26.35%
35,255 $5.16 Million
Q4 2022

Jan 25, 2023

SELL
$129.72 - $159.85 $63,822 - $78,646
-492 Reduced 1.02%
47,871 $0
Q3 2022

Oct 24, 2022

BUY
$126.59 - $161.18 $205,835 - $262,078
1,626 Added 3.48%
48,363 $6.45 Million
Q2 2022

Aug 01, 2022

BUY
$141.59 - $168.66 $268,737 - $320,116
1,898 Added 4.23%
46,737 $7.29 Million
Q1 2022

May 03, 2022

BUY
$129.64 - $160.7 $2.13 Million - $2.64 Million
16,437 Added 57.87%
44,839 $6.98 Million
Q4 2021

Feb 01, 2022

SELL
$119.87 - $145.67 $72,041 - $87,547
-601 Reduced 2.07%
28,402 $3.62 Million
Q3 2021

Oct 26, 2021

BUY
$128.64 - $184.79 $3.73 Million - $5.36 Million
29,003 New
29,003 $3.78 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Calamos Wealth Management LLC Portfolio

Follow Calamos Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Calamos Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Calamos Wealth Management LLC with notifications on news.